The inhibition of MPO has been proposed as a strategy for resolution of inflammation in the context of IBD [57], atherosclerosis [130,163], neurodegenerative disorders [138,140], cancer [164], and infections [82,165]. This evidence concerns the gene MPO and atherosclerosis.